Previous 10 | Next 10 |
PARSIPPANY, N.J., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 31 st Annual Piper Jaffray Healthcare Conference at 9:30 AM on Tuesday, December 3, 2019. Live audio of the event can be accessed by visiting the ...
PARSIPPANY, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the Jefferies 2019 London Healthcare Conference at 2:40 PM GMT (9:40AM ET) on Wednesday, November 20, 2019. Live audio of the event can be accessed by visit...
Image source: The Motley Fool. Pacira Pharmaceuticals Inc (NASDAQ: PCRX) Q3 2019 Earnings Call Nov 7, 2019 , 8:30 a.m. ET Operator Continue reading
Pacira BioSciences, Inc. (PCRX) Q3 2019 Results Earnings Conference Call November 7, 2019, 8:30 AM ET Company Participants Susan Mesco - Head, Investor Relations Dave Stack - Chairman and CEO Dr. Richard Scranton - Chief Medical Officer Charlie Reinhardt - Chief Financial Offic...
Pacira Pharmaceuticals (NASDAQ: PCRX ): Q3 Non-GAAP EPS of $0.48 beats by $0.16 ; GAAP EPS of -$0.15 misses by $0.20 . Revenue of $104.7M (+25.5% Y/Y) misses by $0.18M . Press Release More news on: Pacira BioSciences, Inc., Earnings news and commentary, Healthcare stocks news,
-- Total revenues increased 25 percent over prior year to $104.7 million in third quarter -- -- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain man...
PARSIPPANY, N.J., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday, November 7, 2019. Following the release, the company will host a live conferenc...
PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +21% on end of PB2452 trial . More news on: PhaseBio Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., Philip Morris International Inc., Stocks on the move, Read more ...
NEW YORK , Sept. 24, 2019 /PRNewswire/ -- Pacira BioSciences Inc. (NASD: PCRX) will replace Shutterfly Inc. (NASD: SFLY) in the S&P SmallCap 600 effective prior to the open of trading on Monday, September 30 . Apollo Global Management Inc. (NYSE: APO) is acquiring Shutterfly in a tra...
Pacira BioSciences (NASDAQ: PCRX ) is up 1.9% postmarket after word it's joining the S&P SmallCap 600 . More news on: Pacira BioSciences, Inc., Shutterfly, Inc., Healthcare stocks news, Stocks on the move Read more ...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., May 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced the pricing of $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule...
TAMPA, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, $250.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement...
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of...